14 results
Early Breast Cancer - Management Algorithm

#breast #cancer #malignancy #algorithm #oncology #early
Early Breast Cancer ... - Management Algorithm ... #breast #cancer ... #malignancy #algorithm ... #oncology #early
Dyspnea - Considerations with Malignancy
Directly Malignancy Related:
 - Lymphangitic spread to lung
 - Malignant pleural effusion
Considerations with Malignancy ... Directly Malignancy ... Treatment Related: - Chemotherapy ... differential #diagnosis #oncology ... #cancer #malignancy
Approach to the Rash in a an oncology patient - MINT-C Mnemonic
M - Malignancy: Leukemia cutis,
the Rash in a an oncology ... Mnemonic M - Malignancy ... Adverse Reactions, Chemotherapy ... #skin #Rash #oncology ... differential #diagnosis #cancer
Treatment of breast cancer: a simplified view
surgical therapy - 5-7 weeks
 - lumpectomy +
 - radiation
Treatment of breast cancer ... mastectomy systemic chemotherapy ... BrighamChiefs #breast #cancer ... #treatment #management ... timeline #simplified #oncology
Oncologic Emergencies - Differential Diagnosis Framework

HEMATOLOGIC ONCOLOGIC EMERGENCIES:
Hyperviscosity Syndrome:
 • Spontaneous bleeding
 • Shortness of breath
EMERGENCIES:: Malignant ... (chest wall) Malignant ... decline in mental function ... #emergencies #oncology ... differential #diagnosis #cancer
Patient risk stratification algorithm for the treatment of cancer-associated thrombosis.

Currently, edoxaban and rivaroxaban are the only
the treatment of cancer-associated ... #DOAC #VTE #Malignancy ... #Cancer #Algorithm ... Anticoagulation #Management ... #Hematology #Oncology
Testicular Cancer - Treatment Related Toxicities

Bleomycin, Cisplatin, Etoposide, lfosfamide
Tinnitus & Hearing Loss
Neurotoxicity
Pulmonary Fibrosis
Hypotension
Nephrotoxicity
Skin Hyperpigmentation
Hemorrhagic Cystitis
Myelosuppression
Peripheral Neuropathy

Ashley
Testicular Cancer ... #Testicular #Cancer ... #chemotherapy # ... toxicology #Toxicities #pharmacology ... #oncology
Treatment algorithm for VTE in Malignancy

(A) Suggested treatment algorithm for symptomatic and incidental DVT or PE
algorithm for VTE in Malignancy ... thrombosis in cancer ... #DOAC #VTE #Malignancy ... Anticoagulation #Management ... #Hematology #Oncology
Checkpoint inhibitors and indications
Anti CTLA-4 antibody:
 • Ipilimumab: Malignant melanoma, Renal cell cancer
Anti-PD-1 antibody:
 • Nivolumab:
• Ipilimumab: Malignant ... • Nivolumab: Malignant ... , Malignant mesothelioma ... #indications #oncology ... #pharmacology
(DOAC interactions) Cancer-treatment specific inducers (↑) and inhibitors (↓)
of cytochrome p450 CYP3A4 and P-glycoprotein.

DOACs are substrates
interactions) Cancer-treatment ... inducers #inhibitors #Chemotherapy ... #Oncology #Hematology ... Interactions #Table #Pharmacology